Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03931772 · ClinicalTrials.gov registry record · NA
Online Automated Self-Hypnosis Program
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 152
- Enrollment target
NCT03931772: Completed NA study, sponsored by Stanford University.
NCT03931772 is a NA study that has completed, run by Stanford University. The registered enrollment target is 152 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03931772, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
Study Summary
After developing professional quality materials (audio) for an affordable automated self-hypnosis intervention program for facilitating smoking cessation, stress and pain reduction, researchers aim to gain qualitative reviews of this program, and test its initial feasibility and effects on smoking cessation and reduction in pain and stress. In addition, this study seeks to determine whether higher hypnotizability, as measured by the Hypnotic Induction Profile (assessed at baseline), is a moderator of improved outcome in these conditions.
Interventions
- BEHAVIORAL Automated Self-Hypnosis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2017-09-05 |
| Est. Completion | 2022-02-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03931772
The ClinicalTrials.gov registry entry for NCT03931772 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Automated Self-Hypnosis is the first listed.
NCT03931772 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03931772 about?
NCT03931772 is a clinical study titled "Online Automated Self-Hypnosis Program". After developing professional quality materials (audio) for an affordable automated self-hypnosis intervention program for facilitating smoking cessation, stress and pain reduction, researchers aim to gain qualitative reviews of this program, and test its initial feasibility and effects on smoking c...
What is the current status of trial NCT03931772?
This trial is currently completed. It is a NA study. The enrollment target is 152 participants. The study started on 2017-09-05. Estimated completion is 2022-02-25.
What interventions are being tested in trial NCT03931772?
The interventions under investigation include: Automated Self-Hypnosis (BEHAVIORAL).
Who is sponsoring clinical trial NCT03931772?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.